Please login to the form below

Not currently logged in
Email:
Password:

Stratatech

This page shows the latest Stratatech news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma

The company snapped up Infacare for £425m earlier this year to claim a treatment for jaundice, added regenerative medicine firm Stratatech for an undisclosed sum last in 2016 and has also

Latest news

  • Ireland's Mallinckrodt buys US regenerative medicine firm Ireland's Mallinckrodt buys US regenerative medicine firm

    Ireland's Mallinckrodt buys US regenerative medicine firm. Stratatech’ s StrataGraft in phase III testing for burns treatment. ... Stratatech has been targeting approval of the biologic in 2020 and says it has patent protection for StrataGraft until

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics